We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+7.19%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.41B
AUM Growth
+$62.9M
(+1.9%)
Cap. Flow
-$51.7M
Cap. Flow
% of AUM
-1.51%
Top 10 Holdings %
Top 10 Hldgs %
24.31%
Holding
517
New
48
Increased
183
Reduced
127
Closed
66
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nordstrom
JWN
|
+$57M |
| 2 |
Amgen
AMGN
|
+$56.3M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$48.4M |
| 4 |
VMW
VMware, Inc
VMW
|
+$40M |
| 5 |
Illinois Tool Works
ITW
|
+$38.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$72.9M |
| 2 |
C.H. Robinson
CHRW
|
+$68M |
| 3 |
Centene
CNC
|
+$47.2M |
| 4 |
Visteon
VC
|
+$40.3M |
| 5 |
Factset
FDS
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.18% |
| 2 | Healthcare | 17.1% |
| 3 | Consumer Discretionary | 16.84% |
| 4 | Communication Services | 12.06% |
| 5 | Industrials | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AVDL
201
DELISTED
Avadel Pharmaceuticals
AVDL
| $377K | 0.01% |
30,430
+650
| +2% | +$8.49K |
2016 Q2
1 quarter
|
|
202
Exelixis
EXEL
$15.4B
| $376K | 0.01% |
29,410
| – | – |
2015 Q3
4 quarters
|
|
203
DELISTED
Radius Health, Inc.
RDUS
| $376K | 0.01% |
6,950
| – | – |
2016 Q1
2 quarters
|
|
204
Arrow Financial
AROW
$683M
| $374K | 0.01% |
13,996
+277
| +2% | +$7.01K |
2013 Q3
12 quarters
|
|
205
Puma Biotechnology
PBYI
$507M
| $371K | 0.01% |
+5,540
| New | +$280K |
2016 Q3
0 quarters
|
|
206
DELISTED
Exact Sciences
EXAS
| $359K | 0.01% |
19,340
| – | – |
2016 Q2
1 quarter
|
|
207
Bel Fuse Inc Class B
BELFB
$3B
| $354K | 0.01% |
+14,670
| New | +$313K |
2016 Q3
0 quarters
|
|
|
ALDR
208
DELISTED
Alder Biopharmaceuticals
ALDR
| $353K | 0.01% |
10,760
-20
| -0.2% | -$609 |
2016 Q2
1 quarter
|
|
209
DELISTED
ARC Document Solutions, Inc.
ARC
| $350K | 0.01% |
93,520
+1,770
| +2% | +$6.41K |
2016 Q2
1 quarter
|
|
210
Vanda Pharmaceuticals
VNDA
$244M
| $348K | 0.01% |
+20,930
| New | +$282K |
2016 Q3
0 quarters
|
|
211
Halozyme
HALO
$13.8B
| $341K | 0.01% |
28,200
| – | – |
2015 Q3
4 quarters
|
|
212
NetEase
NTES
$80.7B
| $340K | 0.01% |
7,065
| – | – |
2015 Q4
3 quarters
|
|
213
Argan
AGX
$4.85B
| $335K | 0.01% |
5,660
-3,880
| -41% | -$190K |
2013 Q2
13 quarters
|
|
214
American Public Education
APEI
$900M
| $330K | 0.01% |
16,680
+310
| +2% | +$7.51K |
2016 Q2
1 quarter
|
|
|
ISEE
215
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $311K | 0.01% |
6,740
+1,810
| +37% | +$102K |
2015 Q2
5 quarters
|
|
216
Anika Therapeutics
ANIK
$268M
| $309K | 0.01% |
6,460
+130
| +2% | +$6.42K |
2013 Q2
13 quarters
|
|
|
GTS
217
DELISTED
Triple-S Management Corporation
GTS
| $307K | 0.01% |
14,726
+294
| +2% | +$6.58K |
2013 Q4
11 quarters
|
|
218
Myriad Genetics
MYGN
$381M
| $298K | 0.01% |
14,500
| – | – |
2015 Q4
3 quarters
|
|
|
ANW
219
DELISTED
Aegean Marine Petroleum Network
ANW
| $297K | 0.01% |
29,670
+590
| +2% | +$4.91K |
2015 Q4
3 quarters
|
|
|
HALL
220
DELISTED
Hallmark Financial Services, Inc.
HALL
| $281K | 0.01% |
2,735
-62
| -2% | -$6.63K |
2016 Q1
2 quarters
|
|
221
Community Trust Bancorp
CTBI
$1.36B
| $273K | 0.01% |
7,360
-530
| -7% | -$19.1K |
2014 Q3
8 quarters
|
|
|
RUTH
222
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $272K | 0.01% |
19,290
-480
| -2% | -$7.34K |
2013 Q3
12 quarters
|
|
223
Ryerson Holding Corp
RYZ
$1.43B
| $269K | 0.01% |
23,790
+1,090
| +5% | +$14.7K |
2016 Q2
1 quarter
|
|
224
Movado Group
MOV
$733M
| $268K | 0.01% |
12,490
+250
| +2% | +$5.6K |
2015 Q2
5 quarters
|
|
225
American Coastal Insurance
ACIC
$525M
| $261K | 0.01% |
+15,380
| New | +$244K |
2016 Q3
0 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q3 2016 Portfolio in Review
As of Q3 2016, Smith Group Asset Management held 517 positions worth $3.41B, up 1.9% from $3.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Smith Group Asset Management's Q3 2016 filing shows 48 new, 183 increased, 127 reduced and 66 closed positions. Its largest new stake was Nordstrom: 1,213,747 shares worth $63M. The largest sale was Bristol-Myers Squibb, an estimated $72.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Smith Group Asset Management's largest Q3 2016 buy was Nordstrom: 1,213,747 shares worth $63M.
- Smith Group Asset Management added most to Alphabet (Google) Class A in Q3 2016, an estimated $48.4M increase.
- Smith Group Asset Management's biggest Q3 2016 reduction was Centene, cutting an estimated $47.2M.
- Smith Group Asset Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $72.9M.
- Smith Group Asset Management's ten largest holdings make up 24% of its $3.41B portfolio in Q3 2016.
- Smith Group Asset Management opened 48 new positions and closed 66 in Q3 2016.
- Smith Group Asset Management's portfolio value rose 1.9% quarter-over-quarter to $3.41B.
Based on Smith Group Asset Management's 13F filing for Q3 2016, filed 2 Nov 2016.